Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,433 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Drug-related and psychopathological symptoms in HIV-positive men who have sex with men who inject drugs during sex (slamsex): Data from the U-SEX GESIDA 9416 Study.
Dolengevich-Segal H, Gonzalez-Baeza A, Valencia J, Valencia-Ortega E, Cabello A, Tellez-Molina MJ, Perez-Elias MJ, Serrano R, Perez-Latorre L, Martin-Carbonero L, Arponen S, Sanz-Moreno J, De la Fuente S, Bisbal O, Santos I, Casado JL, Troya J, Cervero-Jimenez M, Nistal S, Cuevas G, Correas-Lauffer J, Torrens M, Ryan P; U-SEX GESIDA 9416 Study. Dolengevich-Segal H, et al. Among authors: santos i. PLoS One. 2019 Dec 4;14(12):e0220272. doi: 10.1371/journal.pone.0220272. eCollection 2019. PLoS One. 2019. PMID: 31800575 Free PMC article.
Sexualized Drug Use (Chemsex) Is Associated with High-Risk Sexual Behaviors and Sexually Transmitted Infections in HIV-Positive Men Who Have Sex with Men: Data from the U-SEX GESIDA 9416 Study.
González-Baeza A, Dolengevich-Segal H, Pérez-Valero I, Cabello A, Téllez MJ, Sanz J, Pérez-Latorre L, Bernardino JI, Troya J, De La Fuente S, Bisbal O, Santos I, Arponen S, Hontañon V, Casado JL, Ryan P. González-Baeza A, et al. Among authors: santos i. AIDS Patient Care STDS. 2018 Mar;32(3):112-118. doi: 10.1089/apc.2017.0263. AIDS Patient Care STDS. 2018. PMID: 29620925
Raltegravir plus abacavir/lamivudine in virologically suppressed HIV-1-infected patients: 48-week results of the KIRAL study.
Troya J, Montejano R, Ryan P, Gómez C, Matarranz M, Cabello A, Vera F, Sepúlveda MA, Santos I, Samperiz G, Bachiller P, Boix V, Barrufet P, Cervero M, Sanz J, Solís J, Yllescas M, Valencia E; GESIDA-8715 Study Group. Troya J, et al. Among authors: santos i. PLoS One. 2018 Jun 14;13(6):e0198768. doi: 10.1371/journal.pone.0198768. eCollection 2018. PLoS One. 2018. PMID: 29902204 Free PMC article.
Reinfection by hepatitis C virus following effective all-oral direct-acting antiviral drug therapy in HIV/hepatitis C virus coinfected individuals.
Berenguer J, Gil-Martin Á, Jarrin I, Montes ML, Domínguez L, Aldámiz-Echevarría T, Téllez MJ, Santos I, Troya J, Losa JE, Serrano R, De Guzmán MT, Calvo MJ, González-García JJ; Madrid-CoRe Study Group. Berenguer J, et al. Among authors: santos i. AIDS. 2019 Mar 15;33(4):685-689. doi: 10.1097/QAD.0000000000002103. AIDS. 2019. PMID: 30829744
Randomized Trial Evaluating the Neurotoxicity of Dolutegravir/Abacavir/Lamivudine and Its Reversibility After Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide: GESIDA 9016.
Perez Valero I, Cabello A, Ryan P, De La Fuente-Moral S, Santos I, Vivancos MJ, Gonzalez A, Gorgolas M, Cuevas G, Diaz De Santiago A, Cano J, Rua G, Yllescas M, González García JJ. Perez Valero I, et al. Among authors: santos i. Open Forum Infect Dis. 2020 Oct 18;7(12):ofaa482. doi: 10.1093/ofid/ofaa482. eCollection 2020 Dec. Open Forum Infect Dis. 2020. PMID: 33335931 Free PMC article.
Epidemiological trends of HIV/HCV coinfection in Spain, 2015-2019.
Fanciulli C, Berenguer J, Busca C, Vivancos MJ, Téllez MJ, Domínguez L, Domingo P, Navarro J, Santos J, Iribarren JA, Morano L, Artero A, Moreno J, Rivero-Román A, Santos I, Giner L, Armiñanzas C, Montero M, Manzardo C, Cifuentes C, García C, Galindo MJ, Ferrero OL, Sanz J, de la Fuente B, Rodríguez C, Gaspar G, Pérez L, Losa JE, Force L, Veloso S, Martínez-Alfaro E, Jarrín I, De Miguel M, González Garcia J; GeSIDA 8514 Study Group. Fanciulli C, et al. Among authors: santos j, santos i. HIV Med. 2022 Aug;23(7):705-716. doi: 10.1111/hiv.13229. Epub 2022 Jan 17. HIV Med. 2022. PMID: 35037379 Free PMC article.
All-oral direct-acting antiviral therapy against hepatitis C virus (HCV) in human immunodeficiency virus/HCV-coinfected subjects in real-world practice: Madrid coinfection registry findings.
Berenguer J, Gil-Martin Á, Jarrin I, Moreno A, Dominguez L, Montes M, Aldámiz-Echevarría T, Téllez MJ, Santos I, Benitez L, Sanz J, Ryan P, Gaspar G, Alvarez B, Losa JE, Torres-Perea R, Barros C, Martin JVS, Arponen S, de Guzmán MT, Monsalvo R, Vegas A, Garcia-Benayas MT, Serrano R, Gotuzzo L, Menendez MA, Belda LM, Malmierca E, Calvo MJ, Cruz-Martos E, González-García JJ. Berenguer J, et al. Among authors: santos i. Hepatology. 2018 Jul;68(1):32-47. doi: 10.1002/hep.29814. Epub 2018 Apr 27. Hepatology. 2018. PMID: 29377274 Free PMC article.
Phenotype or virtual phenotype for choosing antiretroviral therapy after failure: a prospective, randomized study.
Perez-Elias MJ, Garcia-Arota I, Muñoz V, Santos I, Sanz J, Abraira V, Arribas JR, González J, Moreno A, Dronda F, Antela A, Pumares M, Martí-Belda P, Casado JL, Geijos P, Moreno S; Realvirfen study group. Perez-Elias MJ, et al. Among authors: santos i. Antivir Ther. 2003 Dec;8(6):577-84. Antivir Ther. 2003. PMID: 14760891 Clinical Trial.
Etravirine-based antiretroviral therapy in HIV/hepatitis C virus coinfected advanced fibrosis patients receiving triple therapy against hepatitis C virus with telaprevir.
Ramirez ML, Vargas FX, González-Garcia J, Quereda C, Pérez-Elías MJ, de Cea AM, Barros C, Condés E, Moreno JS, Santos I, Torralba M, Aldamiz-Echevarria T, Moreno A. Ramirez ML, et al. Among authors: santos i. AIDS. 2014 Oct 23;28(16):2487-9. doi: 10.1097/QAD.0000000000000425. AIDS. 2014. PMID: 25265233 No abstract available.
2,433 results